Low frequency of the glutathione-S-transferase T1-null genotype in patients with primary myelodysplastic syndrome and 5q deletion

被引：0
|
作者：
C Stavropoulou
C Sambani
H Rigana
V N Georgakakos
G Voutsinas
K N Manola
G E Pantelias
V Makropoulos
机构：
[1] Laboratory of Health Physics and Environmental Health,Department of Occupational and Industrial Hygiene
[2] NCSR ‘Demokritos’,undefined
[3] Laboratory of Environmental Mutagenesis and Carcinogenesis,undefined
[4] NCSR ‘Demokritos’,undefined
[5] National School of Public Health,undefined
[6] Athens,undefined
[7] Greece. E-mail: csambani@ipta.demokritos.gr,undefined
来源：
Leukemia | 2008年 / 22卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1643 / 1646
页数：3
相关论文
共 50 条
  • [41] Treatment-related toxicity after haematopoietic stem cell transplantation and deletion polymorphisms in glutathione-S-transferase M1 and glutathione-S-transferase T1 in different ethnic populations of patients
    Zhelnova, E.
    Hahn, T.
    McCarthy, P.
    Demidova, I.
    Misiurin, A.
    Parovitchnikova, E.
    Savchenko, V.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S99 - S99
  • [42] Hemoglobin adducts from acrylonitrile and ethylene oxide in cigarette smokers:: Effects of glutathione S-transferase T1-null and M1-null genotypes
    Fennell, TR
    MacNeela, JP
    Morris, RW
    Watson, M
    Thompson, CL
    Bell, DA
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2000, 9 (07) : 705 - 712
  • [43] Short Telomeres Before Lenalidomide Treatment Predict Leukemic Progression In Patients with Myelodysplastic Syndrome and Deletion 5q
    Gohring, Gudrun
    Lange, Kathrin
    Hofmann, Winfried
    Nielsen, Kirsten Vang
    Hellstrom-Lindberg, Eva
    Roy, Lydia
    Morgan, Michael
    Kreipe, Hans
    Buesche, Guntram
    Giagounidis, Aristoteles
    Schlegelberger, Brigitte
    BLOOD, 2010, 116 (21) : 18 - 18
  • [44] Adjusted dose lenalidomide is safe and effective in patients with deletion (5q) myelodysplastic syndrome and severe renal impairment
    Knop, Stefan
    Einsele, Hermann
    Bargou, Ralf
    Cosgrove, Denise
    List, Alan
    LEUKEMIA & LYMPHOMA, 2008, 49 (02) : 346 - 349
  • [45] Telomere shortening, clonal evolution and disease progression in myelodysplastic syndrome patients with 5q deletion treated with lenalidomide
    G Göhring
    K Lange
    W Hofmann
    K V Nielsen
    E Hellström-Lindberg
    L Roy
    M Morgan
    H Kreipe
    G Büsche
    A Giagounidis
    B Schlegelberger
    Leukemia, 2012, 26 : 356 - 358
  • [46] IMMUNOPHENOTYPIC DESCRIPTION OF PATIENTS WITH A MYELODYSPLASTIC SYNDROME AND 2 SPECIFIC CYTOGENETICS ABNORMALITIES: DELETION OF 5Q AND TRISOMY 8
    Subira, M.
    Font, P.
    Arranz, E.
    Serrano, C.
    Gonzalo, R.
    Castanon, S.
    Mata, R.
    Soto, C.
    Olaso, E.
    Roman, A.
    Lamas, P. L.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 289 - 289
  • [47] Response to lenalidomide in patients with myelodysplastic syndrome with deletion 5q: clinical and cytogenetic analysis of a single centre series
    Coutinho, Rita
    Costa, Dolors
    Carrio, Ana
    Munoz, Concha
    Vidal, Ana
    Belkaid, Mohammed
    Campo, Elias
    Nomdedeu, Benet
    ANNALS OF HEMATOLOGY, 2010, 89 (10) : 1069 - 1070
  • [48] Association Between Polycystic Ovary Syndrome and the Polymorphisms of Aryl Hydrocarbon Receptor Repressor, Glutathione-S-transferase T1, and Glutathione-S-transferase M1 Genes
    Chung, Youn Kyung
    Kim, Jin Ju
    Hong, Min A.
    Hwang, Kyu Ri
    Chae, Soo Jin
    Yoon, Sang Ho
    Choi, Young Min
    GYNECOLOGICAL ENDOCRINOLOGY, 2021, 37 (06) : 558 - 561
  • [49] Response to lenalidomide in patients with myelodysplastic syndrome with deletion 5q: clinical and cytogenetic analysis of a single centre series
    Rita Coutinho
    Dolors Costa
    Ana Carrió
    Concha Muñoz
    Ana Vidal
    Mohammed Belkaid
    Elias Campo
    Benet Nomdedeu
    Annals of Hematology, 2010, 89 : 1069 - 1070
  • [50] Telomere shortening, clonal evolution and disease progression in myelodysplastic syndrome patients with 5q deletion treated with lenalidomide
    Goehring, G.
    Lange, K.
    Hofmann, W.
    Nielsen, K. V.
    Hellstrom-Lindberg, E.
    Roy, L.
    Morgan, M.
    Kreipe, H.
    Buesche, G.
    Giagounidis, A.
    Schlegelberger, B.
    LEUKEMIA, 2012, 26 (02) : 356 - 358
12345